Dh. Wang et al., Control of type II transforming growth factor-beta receptor expression by integrin ligation, J BIOL CHEM, 274(18), 1999, pp. 12840-12847
Ectopic expression of the alpha(5) integrin subunit in cancer cells with li
ttle or no endogenous expression of this integrin often results in reduced
proliferation as well as reduced malignancy, We now show that inhibition re
sulting from ectopic expression of alpha(5) integrin is due to induction of
autocrine negative transforming growth factor-beta (TGF-beta) activity. MC
F-7 breast cancer cells do not express either alpha(5) integrin or type II
TGF-beta receptor and hence are unable to generate TGF-beta signal transduc
tion. Ectopic expression of cy,integrin expression enhanced cell adhesion t
o fibronectin, reduced proliferation, and increased the expression of type
II TGF-beta receptor mRNA and cell surface protein. Receptor expression was
increased to a higher level in alpha(5) transfectants by growth on fibrone
ctin-coated plates. Induction of type II TGF-beta receptor expression also
resulted in the generation of autocrine negative TGF-beta activity because
colony formation was increased after TGF-beta neutralizing antibody treatme
nt. Transient transfection with a TGF-beta promoter response element in tan
dem with a luciferase cDNA into cells stably transfected with cu, integrin
resulted in basal promoter activities 5-10-fold higher than those of contro
l cells. Moreover, when alpha(5) transfectants were treated with a neutrali
zing antibody to either TGF-beta or integrin alpha(5), this increased basal
promoter activity was blocked, Autocrine TGF-beta activity also induced 3-
fold higher endogenous fibronectin expression in alpha(5) transfectants rel
ative to that of control cells, Re-expression of type II receptor by alpha(
5) transfection also restored the ability of the cells to respond to exogen
ous TGF-beta and led to reduced tumor growth in athymic nude mice. Taken to
gether, these results show for the first time that TGF-beta type II recepto
r expression can be controlled by alpha(5)beta(1) ligation and integrin sig
nal transduction, Moreover, TGF-beta and integrin signal transduction appea
r to cooperate in their tumor-suppressive functions.